Shawn Cline Tomasello's Insider Trades & SAST Disclosures
Shawn Cline Tomasello's most recent trade in Cabaletta Bio Inc was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shawn Cline Tomasello.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 44,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 70,000 | - | 0 | Common Stock | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| Gamida Cell Ltd | Tomasello Shawn Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 241,977 | - | 0 | Ordinary Shares | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 17,000 | 17,000 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 41,977 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 13,677 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Shawn Cline Tomasello | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 Sep 2022 | 9,677 | 11,677 | - | 1.5 | 14,999 | Ordinary Shares |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| UroGen Pharma Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| UroGen Pharma Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges